AAAAAA
Results: 1-25/30
Authors:
Salminen, E
Rintala, J
Harkonen, J
Kuitunen, M
Hogmander, H
Oikari, A
Citation: E. Salminen et al., Anaerobically digested poultry slaughterhouse wastes as fertiliser in agriculture, BIORES TECH, 78(1), 2001, pp. 81-88
Authors:
Teppo, L
Salminen, E
Pukkala, E
Citation: L. Teppo et al., Risk of a new primary cancer among patients with lung cancer of different histological types, EUR J CANC, 37(5), 2001, pp. 613-619
Authors:
Salminen, E
Einola, J
Rintala, J
Citation: E. Salminen et al., Characterisation and anaerobic batch degradation of materials accumulatingin anaerobic digesters treating poultry slaughterhouse waste, ENV TECHNOL, 22(5), 2001, pp. 577-585
Authors:
Salminen, E
Mac Manus, M
Citation: E. Salminen et M. Mac Manus, Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer, ANN MED, 33(6), 2001, pp. 404-409
Authors:
Mouridsen, H
Gershanovich, M
Sun, Y
Perez-Carrion, R
Boni, C
Monnier, A
Apffelstaedt, J
Smith, R
Sleeboom, HP
Janicke, F
Pluzanska, A
Dank, M
Becquart, D
Bapsy, PP
Salminen, E
Snyder, R
Lassus, M
Verbeek, JA
Staffler, B
Chaudri-Ross, HA
Dugan, M
Citation: H. Mouridsen et al., Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group, J CL ONCOL, 19(10), 2001, pp. 2596-2606
Authors:
Ahokoski, O
Irjala, K
Taalikka, M
Manninen, P
Halonen, K
Kangas, L
Salminen, E
Huupponen, R
Scheinin, H
Citation: O. Ahokoski et al., Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men, BR J CL PH, 52(6), 2001, pp. 702-704
Authors:
Kailajarvi, M
Ahokoski, O
Virtanen, A
Salminen, E
Irjala, K
Citation: M. Kailajarvi et al., Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests, ANTICANC R, 21(4B), 2001, pp. 2867-2872
Authors:
Salminen, E
Kankuri, M
Nuutila, J
Lilius, EM
Pellimiemi, TT
Citation: E. Salminen et al., Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha, ANTICANC R, 21(3B), 2001, pp. 2049-2055
Authors:
Sundstrom, J
Salminen, E
Nurmi, M
Toppari, J
Pollanen, P
Pelliniemi, LJ
Huhtala, S
Rajala, P
Laato, M
Citation: J. Sundstrom et al., Management of testicular cancer - 16 years' experience from southwest Finland, SC J UROL N, 35(1), 2001, pp. 21-25
Authors:
Kankuri, M
Pelliniemi, TT
Pyrhonen, S
Nikkanen, V
Helenius, H
Salminen, E
Citation: M. Kankuri et al., Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - A phase II study, CANCER, 92(4), 2001, pp. 761-767
Authors:
Mac Manus, MP
Hicks, RJ
Ball, DL
Kalff, V
Matthews, JP
Salminen, E
Khaw, P
Wirth, A
Rischin, D
McKenzie, A
Citation: Mp. Mac Manus et al., F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma - Powerful correlation with survival and high impact on treatment, CANCER, 92(4), 2001, pp. 886-895
Authors:
Kailajarvi, M
Ahokoski, O
Virtanen, A
Salminen, E
Irjala, K
Citation: M. Kailajarvi et al., Alterations in laboratory test results during adjuvant breast cancer treatment, CLIN CH L M, 38(5), 2000, pp. 443-451
Authors:
Sundstrom, J
Pelliniemi, LJ
Salminen, E
Pollanen, P
Abdelwahid, E
Verajankorva, E
Soderstrom, KO
Citation: J. Sundstrom et al., Effect of etoposide on experimental testicular teratoma in 129/SvJ mice, VIRCHOWS AR, 436(6), 2000, pp. 608-616
Authors:
Salminen, E
Sundstrom, J
Sainio-Pollanen, S
Pollanen, P
Kaprio, J
Citation: E. Salminen et al., Testicular seminoma and diabetes in twins, ACTA ONCOL, 39(2), 2000, pp. 237-238
Authors:
Salminen, E
Rintala, J
Lokshina, LY
Vavilin, VA
Citation: E. Salminen et al., Anaerobic batch degradation of solid poultry slaughterhouse waste, WATER SCI T, 41(3), 2000, pp. 33-41
Authors:
Ouwehand, AC
Tolkko, S
Kulmala, J
Salminen, S
Salminen, E
Citation: Ac. Ouwehand et al., Adhesion of inactivated probiotic strains to intestinal mucus, LETT APPL M, 31(1), 2000, pp. 82-86
Authors:
Salminen, E
Bergman, M
Huhtala, S
Jekunen, A
Ekholm, E
Citation: E. Salminen et al., Docetaxel, a promising novel chemotherapeutic agent in advanced breast cancer, ANTICANC R, 20(5C), 2000, pp. 3663-3668
Authors:
Ekholm, E
Rantanen, V
Bergman, M
Vesalainen, R
Antila, K
Salminen, E
Citation: E. Ekholm et al., Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients, ANTICANC R, 20(3B), 2000, pp. 2045-2048
Authors:
Kirla, R
Salminen, E
Huhtala, S
Nuutinen, J
Talve, L
Haapasalo, H
Kalimo, H
Citation: R. Kirla et al., Prognostic value of the expression of tumor suppressor genes p53, p21, p16and pRb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy, J NEURO-ONC, 46(1), 2000, pp. 71-80
Authors:
Bergh, J
Wiklund, T
Erikstein, B
Lidbrink, E
Lindman, H
Malmstrom, P
Kellokumpu-Lehtinen, P
Bengtsson, NO
Soderlund, G
Anker, G
Wist, E
Ottosson, S
Salminen, E
Ljungman, P
Holte, H
Nilsson, J
Blomqvist, C
Wilking, N
Citation: J. Bergh et al., Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial, LANCET, 356(9239), 2000, pp. 1384-1391
Authors:
Kiviniemi, N
Sauroja, I
Rajamaki, A
Punnonen, K
Soderstrom, KO
Salminen, E
Citation: N. Kiviniemi et al., Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activity, BR J CANC, 83(9), 2000, pp. 1161-1167
Authors:
Salminen, E
Pukkala, E
Teppo, L
Citation: E. Salminen et al., Second cancers in patients with brain tumours - Impact of treatment, EUR J CANC, 35(1), 1999, pp. 102-105
Authors:
Pyrhonen, S
Salminen, E
Ruutu, M
Lehtonen, T
Nurmi, M
Tammela, T
Juusela, H
Rintala, E
Hietanen, P
Kellokumpu-Lehtinen, PL
Citation: S. Pyrhonen et al., Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer, J CL ONCOL, 17(9), 1999, pp. 2859-2867
Authors:
Salminen, E
Bergman, M
Huhtala, S
Ekholm, E
Citation: E. Salminen et al., Docetaxel: Standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy - A phase II single-center study, J CL ONCOL, 17(4), 1999, pp. 1127-1131
Authors:
Sundstrom, J
Verajankorva, E
Salminen, E
Pelliniemi, LJ
Pollanen, P
Citation: J. Sundstrom et al., Experimental testicular teratoma promotes formation of humoral immune responses in the host testis, J REPRO IMM, 42(2), 1999, pp. 107-126